Melissa joined Brandon Capital in 2008.
Before joining Brandon Capital, Melissa was an investor with Terra Rossa Capital in Adelaide, a Fund Manager specialising in seed-to-early-stage life science investment. Previously, Melissa was a Business Development Manager with Bio Innovation SA where she helped early-stage companies refine their business plans and prepare to raise capital. Prior to joining Bio Innovation SA, Melissa worked with an early-stage medical device company in Adelaide, assisting with capital raising. Melissa spent three years as a postdoctoral scientist at Prince Henry’s Institute of Medical Research, Victoria.
Melissa has a Bachelor of Science (Honours) from the University of Adelaide, a PhD in Immunology from the University of Adelaide and an MBA, specialising in finance, from the University of South Australia. Melissa holds a Graduate Certificate in Applied Finance from Kaplan (formerly FINSIA) and is a graduate of the Australian Institute of Company Directors.
Melissa is currently a director of Cincera Therapeutics and Ankere Therapeutics.
